According to these findings, studies with AD patients demonstrated that PACAP levels were reduced in cortical areas such as the entorhinal cortex, the middle temporal gyrus, the superior frontal gyrus, and the primary visual cortex (Han et al., 2014a). This evidence concerns the gene ADCYAP1 and Alzheimer disease.